欢迎来到 ATTO-TEC中国区代理商/公司/官网
全国咨询热线: 15172431432
联系我们

地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301

电话:17754422825

传真:18771997407

邮箱:sales@amyjet.com

新闻中心
BioPAL.jpg

艾美捷科技特约代理BioPAL全系列产品。


BioPAL公司位于美国马萨诸塞Worcester,服务于生命科学和生物医药行业,主要从事非放射性报告系统的研发、生产、商业化。此外,BioPAL销售用于核磁共振(MRI)的纳米颗粒;BioPAL还提供即用型的细胞标记及示踪产品。

 

BioPhysics Assay Laboratory (BioPAL, Inc.) is a privately held, for-profit company based in Worcester Massachusetts. The company develops and sells novel tools for the life science and biomedical communities. BioPAL was the first company to commercialize non-radioactive products that use neutron activation technology as the read-out system. The company also develops and sells nanoparticles for applications in magnetic resonance imaging (MRI), magnetic separation applications and tools for time resolved fluorescent technology. BioPAL offers ready-to-use cell labeling and tracking products for cellular therapy research applications.

 

BioPAL was the first to introduce functional immunoassay technology (FIT) to the research community. The company offers a line of renal diagnostics based on FIT to measure glomerular filtration rate (GFR) and effective renal blood flow (RBF). Most notably is BioPAL's ELISA kit for the measurement of inulin.

 

BioPAL公司的主要产品包括:

Pre-Clinical Imaging Agents

Kidney Diagnostics

Microspheres for Blood Flow Studies

Dead-Cell Removal Kits - Viahanc

Products for Cellular Therapy Research

" data-original="http://atto.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技特约代理BioPAL全系列产品">
艾美捷科技特约代理BioPAL全系列产品
...
阅读详情
Dovetail Genomics logo.png


艾美捷科技代理Dovetail Genomics品牌全系列产品


Dovetail Genomics公司成立于2013年,是染色体级别基因组组装领域的创新者,Dovetail Genomics公司正在解决包括染色质拓扑结构分析、大小体细胞变异检测、从头染色体组装和单倍型定相在内的复杂问题。Dovetail Genomics通过其专利的Hi-C/Omini-C技术,填补了短读长测序无法完成高质量组装的空白,产品广泛应用于表观遗传学、发育生物学、癌症研究、进化生物学、传染病等领域。


DovetailGenomics页面.png


▍Dovetail Genomics公司的产品


Dovetail Assay
ApplicationLinkPrep™Micro-CHiChIPPan PromoterOmni-C
Genetic VariationLarge Structural Variant
Detection Genotyping
√



Genotyping√



Haplotype Phasing√

√
Chromatin TopologyTargeted Enhancer-
Promoter Interactions





Nucleosome-level
Chromatin Topology

√


Whole Genome Rapid
High-Resolution Topology
√



Protein Anchored
Topology


√

Genetic Genome AssemblyGenome Scaffolding√


√
Hybrid Capture Compatible√√

√


▍Dovetail® LinkPrep™ Kit

采用Tn5转座酶实现染色质均匀片段化,确保捕获无偏差的完整染色质三维构象。产品特点:

● 单日工作流:样本→测序文库仅需8小时(传统Hi-C需3-5天)

● 零专用设备:兼容常规分子生物学实验室

● 实现单倍型定相组装(Haplotype-resolved)

● 同步捕获全谱变异:SNV/InDel/CNV/SV(灵敏度达95%)

● 适用于基因组拓扑结构、遗传变异、基因组组装


▍Dovetail® Micro-C Kit

获取核小体分辨率的三维基因组图谱,针对需要单核小体级别精细拓扑图谱的研究(解析150-200 bp染色质构象),本技术可逐层解锁基因组三维结构。其在1千碱基对(kbp)以下分辨率呈现的高信噪比特性,使研究者能够以显著降低的成本构建高质量的染色质互作矩阵。产品特点:

● 核小体级精度:直接解析 150-200 bp染色质基本单元(单核小体)的空间构象,突破传统Hi-C技术分辨率限制(通常>1 kbp)

● 超高信噪比优势:在亚千碱基级别消除背景噪音,精确捕获微尺度拓扑关联域(如增强子-启动子互作)

● 成本降低:相较冷冻电镜或ChIA-PET等方法,实验成本下降60-80%; 矩阵数据质量提升(矩阵信噪比 > 95%,传统方法约70-85%)


▍Dovetail® Pan Promoter Kit

专为绘制“基因启动子-调控元件”三维互作图谱设计,通过靶向富集技术实现高分辨率、低成本的染色质构象分析。


▍Dovetail® HiChIP Kit

抗体导向的精准三维基因组捕获系统,融合Hi-C空间架构捕获与ChIP靶向富集技术,实现对特定蛋白(如CTCF、Cohesin、组蛋白修饰)介导的染色质互作进行纳米级分辨率解析。产品特点:

● 分辨率:200 bp(单核小体水平)

● 灵敏度:检测低频互作(≥5个细胞中1次事件)

● 特异性:抗体结合位点富集度 >100X;非特异性背景 <2%

● 样本兼容性:冰冻组织、FFPE样本、单细胞悬液


▍Dovetail® Omni-C® Kit

通过Tn5转座酶同时捕获染色质空间互作与酶切位点信息,核心优势:

● 高分辨率:精准解析拓扑关联结构域(TADs)、染色质环

● 多组学整合:单次实验同步检测染色质构象+基因变异(SNV/InDel/CNV/SV)

● 样本兼容性:支持微量样本(>50mg组织/ >10,000个细胞)


" data-original="http://atto.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Dovetail Genomics品牌全系列产品">
艾美捷科技代理Dovetail Genomics品牌全系列产品
...
阅读详情
TriAltusbioscience 2.5比1.png

<

艾美捷科技代理Trialtusbioscience品牌全系列产品


TriAltus Bioscience是一个致力于为推动人类健康前沿的科学家服务的品牌。当今的创新者在推进基因疗法、工程诊断、早期疾病检测以及药物发现等领域,都需要高纯度、高性能且随时可以扩展的酶,TriAltus正是为此而存在。TriAltus的核心是其专有的CLiM™(CL7/Im7)纯化平台,是一种基于亲和标签的突破性系统,能在单个色谱步骤中提供具有卓越纯度、活性和一致性的酶,重新定义了重组蛋白纯化的可能性。 使用CLiM™生产的每种酶都以严格的质量控制、批次间一致性和详细的分析证书(COA)为后盾,旨在满足监管机构要求的质量和文档标准,支持从发现到扩大规模的更平稳过渡。TriAltus Bioscience公司的产品包括:基因组酶、蛋白酶和其他酶。


TriAltusBioscience页面.png


▍Trialtusbioscience产品线

● 基因组酶:TriAltus的重组基因组酶不含标签,并使用专有的CLiM™亲和标签系统进行纯化,提供目录酶的定制缩放和配方,以满足特定研究需求,无论需要更高的浓度、独特的缓冲条件还是批量生产,都可以根据具体规格定制酶。


货号品名规格产品描述
40-1212AapCas12b Protein20 μgexpressed in E. coli and features two C-terminal nuclear localization signals,enables the inactive nuclease to be guided to the specific double stranded DNA site.
40-1220AapCas12b Protein100 μg
40-1225AapCas12b Protein500 μg
40-1320CRISPR-Cas9 Protein100 μgused for genome editing with CRISPR technology. Recombinant Streptococcus pyogenes Cas9 ,expressed in Escherichia coli and features two nuclear localization signals
40-1325CRISPR-Cas9 Protein500 μg
40-2414Phi29 DNA Polymerase3,000 Unitsa highly processive, isothermal enzyme from Bacillus subtilis phage phi29 ,with a robust 3'→5' proofreading exonuclease function.
40-2420Phi29 DNA Polymerase10,000 Units
40-2125TAT-CRE Recombinase500 μgused for site-specific DNA recombination in mammalian cells,a fusion protein combining a nuclear localization sequence, HIV-TAT cell permeabilization peptide, and Cre recombinase.
40-2130TAT-CRE Recombinase1 mg
40-2135TAT-CRE Recombinase5 mg


● 蛋白酶和其他酶:例如为冷冻电镜生成蛋白质的实验室提供SUMO蛋白酶,去除相关标签后蛋白质可进行分析,反应高效、稳健,无需优化,客户对酶的性能和优质客户服务感到满意。


货号品名规格产品描述
30-2130PreScission Protease1 mgrecognizes and cleaves the sequence LEVLFQ/GP  to release the target protein from the Im7-bound CL7 tag
30-2135PreScission Protease5 mg
30-2140PreScission Protease10 mg
30-2146PreScission Protease50 mg
30-2150PreScission Protease100 mg
30-1130SUMO Protease1 mgreleases target proteins from TriAltus’s Im7 resin,recognizes SUMO tertiary structure – not a specific amino acid sequence – to cleave and release the target protein from the Im7-bound CL7 tag.
30-1135SUMO Protease5 mg
30-1140SUMO Protease10 mg
30-1146SUMO Protease50 mg
30-1150SUMO Protease100 mg



" data-original="http://atto.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Trialtusbioscience品牌全系列产品">
艾美捷科技代理Trialtusbioscience品牌全系列产品
...
阅读详情
66979d156892f.jpg

艾美捷科技代理Pluriselect品牌。


PluriSelect Life Science是一家德国生物技术公司,为免疫学、基础科学和诊断领域的研究提供细胞和蛋白质分离优化产品。


Pluriselect细胞过滤器的特点:

1)提供种类繁多的细胞过滤器,几乎可以满足所有需求

2)是市场上细胞过滤器之一,具有许多附加功能,而大多数类似的基本细胞过滤器(如Falcon™或EASYstrainer™)都没有这些功能。

3)有19种网眼尺寸可供选择,适用于需要过滤和净化液体的各种实验室应用。

4)具有流量控制功能(与连接器环结合)的经济实惠的细胞过滤器系统的最佳选择

5)pluriStrainer®Mini是几乎所有反应管(15ml至1.5ml,24/48孔板)中最灵活的小型细胞过滤器配件

6)独特的设计可改善通风,避免堵塞,从而实现智能样品制备。

7)pluriStrainer®可堆叠,以允许使用不同的网目尺寸进行直接过滤,也可以倒置以回收筛分的材料,对于大样本量,它可以与漏斗结合使用。


微信截图_20250205163845.png


Pluriselect细胞过滤器

1)消化乳腺组织和类器官后获得真正的单细胞悬浮液

2)使用pluriBead技术富集特定细胞

3)骨髓、胰腺、胸腺、淋巴结等血细胞的单细胞悬液的制备

4)细胞与其他原代组织的解离

5)流式细胞术用真实单细胞悬液的制备(FACS™)

6)纱布过滤的更快、更简单的替代品

7)复杂和粘性液体的筛分(与真空连接环和注射器结合使用)

8)细胞/细胞因子的短时间孵育(与pluriBead和连接环结合)

产品列表如下:

<
品名货号规格
pluriStrainer 100µm, PET-mesh, 50 pcs, sterile43-50100-5150 pcs
pluriStrainer Mini, 10µm, 50pcs, 25pcs sterile in bag43-10010-5050pcs
pluriStrainer 15µm, 25 pcs, sterile43-50015-0325 pcs
pluriStrainer 20µm, 25 pcs, sterile43-50020-0325 pcs
pluriStrainer 300µm, 25 pcs, sterile43-50300-0325 pcs
pluriStrainer 500µm, 25 pcs, sterile43-50500-0325 pcs
Funnel, 25 pcs, sterile42-50000-0325 pcs
pluriStrainer 30µm, 25 pcs, sterile43-50030-0325 pcs
pluriStrainer 400µm, 50 pcs - non-sterile43-50400-5050 pcs
pluriStrainer Mini 8 µm (membrane, 5 pcs.), sterile46-10008-155 pcs
CD3 S-pluriBead anti-hu, 2ml19-00300-102ml
Centrifuge Tube 15 ml (sterile, 50 pcs.)05-00002-5050 pcs
pluriSpin Human Monocyte Enrichment, 2ml19-01001-312ml
CD11a M-pluriBead anti-hu, 2ml19-011a0-202ml
Centrifuge Tube 50 ml (sterile, 300 pcs.) standing edge05-00004-01300 pcs
pluriSpin Human T Cell Enrichment, 2ml19-02001-312ml
pluriSpin Human T Cell Depletion, 2ml19-02002-312ml
pluriSpin Human CD8+ T Cell Enrichment, 2ml19-04001-312ml
pluriSpin Human CD8+ Cell Depletion, 2ml19-04002-312ml
pluriSpin Human CD4? Cell Depletion, 2ml19-03002-312ml


< " data-original="http://atto.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Pluriselect品牌">
艾美捷科技代理Pluriselect品牌
...
阅读详情
Agrisera.jpg

瑞典Agrisera公司成立于1980年,长期以来,公司致力于植物/环境科学研究中所需蛋白抗体研发与销售,主要集中于模式之物及其他植物的生理、病理相关的蛋白抗体。Agrisera 公司以提供高品质、优服务在欧洲树立了优秀的品牌形象,并成为瑞典 Umeå Plant Science Centre的抗体供货商,同时还积极拓展全球市场,每年都有大批采用该公司抗体产品的高质量研究论文发表于各类学术刊物,受到全球科研工作者的一致认可。Agrisera的所有抗体分两大类:植物及藻类的抗体,以及细菌、真菌、昆虫、鱼等动物类抗体,植物领域的抗体涵盖Arabidopsis thaliana、Hordeum vulgare、Chlamydomonas reinhardtii、Cyanobacteria、Physcomitrella patens、Oryza sativa、Populus sp、Conifers等多个物种。

 

Agrisera is a Swedish company specializing in polyclonal and monoclonal antibody production, offering an extensive collection of primary antibodies and over 2000 secondary antibodies for various applications and in various quantities, all available online. Over 30 years in the antibody business have taught us a lot and we are proud to say there are few problems we cannot help you to solve. Our experienced scientific staff are on hand to answer all your queries promptly.

 

Agrisera公司的主要产品包括:

Plant/Algal antibodies 

Animal/Human antibodies 

Bacterial/Fungal antibodies

Secondary antibodies 

Rapid Western Blotting

Detection reagents 

" data-original="http://atto.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Agrisera">
Agrisera
...
阅读详情
Hampton Research LOGO 2.5比1.jpg

艾美捷科技代理Hampton Research品牌产品。

Hampton Research是一家专注于蛋白质结晶和相关生命科学工具的公司,作为蛋白质结晶领域的重要供应商,Hampton Research提供广泛的产品和服务,帮助科学家在结构生物学、药物开发和生物化学研究中实现高质量的晶体生长,特别是在 X 射线晶体学和冷冻电镜(Cryo-EM)领域。Hampton Research公司主要产品类别包括:


(1)结晶筛选试剂盒

Crystal Screen™ 系列,提供多种结晶条件筛选试剂盒,适用于初步筛选和优化结晶条件。

Index™ 试剂盒,包含广泛的化学条件,用于快速筛选结晶条件。

SaltRx™ 试剂盒,专注于盐类结晶条件的筛选。

PEG/Ion™ 试剂盒,提供基于聚乙二醇(PEG)和离子溶液的结晶条件。


(2)结晶优化试剂

Additive Screen™,包含多种添加剂,用于优化晶体生长。

Crystal CryoProtection™ 试剂,用于保护晶体在低温条件下的完整性。

PEG 溶液和缓冲液,提供不同分子量和浓度的 PEG 溶液,用于结晶实验。


(3)结晶工具和设备

Crystallization Plates,提供多种规格的结晶板,如 24 孔、96 孔和 384 孔板,适用于高通量筛选。

CrystalCap™ 帽盖,用于密封结晶板,防止样品蒸发和污染。

CrystalMiner™ 机器人,自动化结晶实验设备,提高实验效率和一致性。


(4)蛋白质结晶相关试剂

Protein Stabilization Reagents,用于稳定蛋白质样品,提高结晶成功率。

Detergent Screen™,包含多种去污剂,用于膜蛋白结晶。

Nucleation Reagents,促进晶体成核,提高结晶效率。


< " data-original="http://atto.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Hampton Research品牌产品">
艾美捷科技代理Hampton Research品牌产品
...
阅读详情
Anogen.jpg

Anogen-Yes Biotech Laboratories Ltd. 创建于1989年, 位于加拿大多伦多近郊的著名高科技城市密西沙加市。Anogen是加拿大逸士生物技术研究有限公司在国际上的市场经销部门。Anogen-Yes Biotech Laboratories Ltd.研发和生产各种新颖抗体及有关产品,应用广泛的技术平台设计和开发各种单克隆抗体、多克隆抗体、基因工程/人源化抗体、免疫检验用配对抗体、免疫球蛋白、活性多肽、酶联免疫试剂盒[ELISA]、斑点酶联免疫试剂盒[Elispots]和基因重组蛋白质等等。 这些产品主要用于生命科学研究和各种疾病的诊断和防治,包括炎症和自身免疫性疾病、心血管病和癌症等。

 

Anogen is the trade name of Yes Biotech Laboratories Ltd., a Canadian biopharmaceutical company based in Mississauga, Ontario. Founded in 1989, Anogen-Yes Biotech specializes in developing and manufacturing monoclonal antibodies, recombinant proteins, synthetic bioactive peptides, and Enzyme linked immunosorbent assay (ELISA) kits for research as well as diagnostic and therapeutic use.[1] It is also committed to seeking medical treatment of cancer, autoimmune, inflammatory and cardiovascular diseases by developing antibody-based biopharmaceuticals.

 

Anogen的主要产品包括:

Monoclonal Antibodies

Polyclonal Antibodies

Matched Antibody Pairs

ELISA Kits

 

按照研究领域细分:

Inflammatory & Growth Factors

Cell Biology & Molecular Biology

Immunoassay Reagents

Infection & Toxin

Coagulation Factors

Hormone

Neurological Disorder

Tumor Research


品名货号规格
mAb anti-Human TNF-α, CH8810MO-C40003A0.1 mg
mAb anti-Human TNF-α, CH8820, CaptureMO-C40003B0.1 mg
mAb anti-Human TNF-α, C2H9MO-C40003D0.1 mg
mAb anti-Human TNF-α, B1E4, DetectorMO-C40003E0.1 mg
mAb anti-Human TNF-α, C2A7MO-C40003F0.1 mg
mAb anti-Human TNF-α, C5G7MO-C40003G0.1 mg
mAb anti-Human TNF-α, C4C7MO-C40003H0.1 mg
mAb anti-Human IFN-γ, 315MO-C40004D0.1 mg
mAb anti-Human IFN-γ, 165MO-C40004E0.1 mg
mAb anti-Human IFN-γ, 23MO-C40004F0.1 mg
mAb anti-Human CCR1, 293MO-C40005A0.1 mg
mAb anti-Human TGF-β, TB21MO-C40009A0.1 mg
mAb anti-Human TGF-β, 2C5MO-C40009B0.1 mg
mAb anti-Human TGF-β, 2C6MO-C40009D0.1 mg
mAb anti-Human TGF-β, 2E6MO-C40009E0.1 mg
mAb anti-Human TGF-β, 8C4MO-C40009F0.1 mg
mAb anti-Human IL-8, I8-S2, CaptureMO-C40017A0.1 mg
mAb anti-Human IL-8, I8-60, DetectorMO-C40017D0.1 mg
mAb anti-Human IL-8, I8-61MO-C40017E0.1 mg
mAb anti-Human IL-8, 257MO-C40017F0.1 mg
mAb anti-Human IL-8, 807MO-C40017G0.1 mg
mAb anti-Human MCP-1, S8MO-C40021A0.1 mg
mAb anti-Human MCP-1, S14, CaptureMO-C40021B0.1 mg
mAb anti-Human MCP-1, S101, DetectorMO-C40021D0.1 mg
mAb anti-Human MCP-1, 9G10MO-C40021E0.1 mg
mAb anti-Human MCP-1, S382MO-C40021F0.1 mg
mAb anti-Human SAA, 115, CaptureMO-C40028A0.1 mg
mAb anti-Human SAA, 513MO-C40028D0.1 mg
mAb anti-Human SAA, 607, DetectorMO-C40028E0.1 mg
mAb anti-Human SAA, 291MO-C40028G0.1 mg
mAb anti-Human SAA, 504MO-C40028H0.1 mg
mAb anti-Human SAA, 585MO-C40028J0.1 mg
mAb anti-Human SAA, 426MO-C40028K0.1 mg
mAb anti-Human SAA, 38MO-C40028L0.1 mg
mAb anti-Human SAA, 132MO-C40028M0.1 mg
mAb anti-Human SAA, S3MO-C40028N0.1 mg
mAb anti-Human IL-1β, S1H12MO-C40029A0.1 mg
mAb anti-Human IL-1β, S1B7MO-C40029B0.1 mg
mAb anti-Human IL-1β, S3F12MO-C40029G0.1 mg
mAb anti-Human IL-1β, 464MO-C40029H0.1 mg
mAb anti-Human IL-2, 5A8,MO-C40032A0.1 mg
mAb anti-Human IL-2, 9F9,MO-C40032B0.1 mg
mAb anti-Human IL-2, 10C4MO-C40032C0.1 mg
mAb anti-Human IL-2, 8C2MO-C40032D0.1 mg
mAb anti-Human IL-2, 6F11MO-C40032E0.1 mg
mAb anti-Human IL-2, 6B1MO-C40032F0.1 mg
mAb anti-Human EGF, S-21MO-C40044A0.1 mg
mAb anti-Human EGF, S-120MO-C40044B0.1 mg
mAb anti-Human EGF, S-134, CaptureMO-C40044D0.1 mg
mAb anti-Human EGF, S-145MO-C40044E0.1 mg
mAb anti-Human EGF, S-146, DetectorMO-C40044F0.1 mg
mAb anti-Human EGF, S-147MO-C40044G0.1 mg
mAb anti-Human EGF, S-177MO-C40044H0.1 mg
mAb anti-Human G-CSFR, S-1252MO-C40045A0.1 mg
mAb anti-Human G-CSFR, S-1268MO-C40045B0.1 mg
mAb anti-Human G-CSFR, S-1284MO-C40045D0.1 mg
mAb anti-Human G-CSFR, S-1374MO-C40045E0.1 mg
mAb anti-Human G-CSFR, S-425MO-C40045F0.1 mg
mAb anti-Human G-CSFR, S-1390MO-C40045G0.1 mg
mAb anti-Human bFGF, F-343MO-C40046A0.1 mg
mAb anti-Human bFGF, F-74MO-C40046B0.1 mg
mAb anti-Human bFGF, F-474MO-C40046F0.1 mg
mAb anti-Human bFGF, F-3MO-C40046H0.1 mg
mAb anti-Human EPO, 85MO-C40047A0.1 mg
mAb anti-Human M-CSF, 116MO-C40048A0.1 mg
mAb anti-Human M-CSF, 692MO-C40048B0.1 mg
mAb anti-Human M-CSF, 21MO-C40048D0.1 mg
mAb anti-Human MIP-1α, 116MO-C40051A0.1 mg
mAb anti-Human MIP-1α, 125MO-C40051D0.1 mg
mAb anti-Human MIP-1α, 548MO-C40051F0.1 mg
mAb anti-Human MIP-1α, 199MO-C40051G0.1 mg
mAb anti-Human MIP-1α, 400MO-C40051L0.1 mg
mAb anti-Human MIP-1α, 103MO-C40051M0.1 mg
mAb anti-Human MIP-1α, 376MO-C40051N0.1 mg
mAb anti-Human MIP-1α, 426MO-C40051P0.1 mg
mAb anti-Human MCP-3, 113, DetectorMO-C40088A0.1 mg
mAb anti-Human MCP-3, 343MO-C40088B0.1 mg
mAb anti-Human MCP-3, 490MO-C40088D0.1 mg
mAb anti-Human MCP-3, 768MO-C40088E0.1 mg
mAb anti-Human MCP-3, 1057MO-C40088F0.1 mg
mAb anti-Human MCP-3, 542, CaptureMO-C40088G0.1 mg
mAb anti-Human MCP-3, 1015MO-C40088H0.1 mg
mAb anti-Human IL-16, 59MO-C40089G0.1 mg
mAb anti-Human IL-16, 210MO-C40089H0.1 mg
mAb anti-Human IL-16, 323, DetectorMO-C40089J0.1 mg
mAb anti-Human IL-16, 398, CaptureMO-C40089K0.1 mg
mAb anti-Human IL-16, 568MO-C40089M0.1 mg
mAb anti-Human IL-16, 572MO-C40089N0.1 mg
mAb anti-Human GM-CSF, 29MO-C40090A0.1 mg
mAb anti-Human GM-CSF, 59, CaptureMO-C40090B0.1 mg
mAb anti-Human GM-CSF, 429, DetectorMO-C40090D0.1 mg
mAb anti-Human GM-CSF, 204MO-C40090E0.1 mg
mAb anti-Human GM-CSF, 489MO-C40090F0.1 mg
mAb anti-Human GM-CSF, 120MO-C40090G0.1 mg
mAb anti-Human GM-CSF, 26MO-C40090H0.1 mg
mAb anti-Human GM-CSF, 174MO-C40090K0.1 mg
mAb anti-Human GM-CSF, S333MO-C40090L0.1 mg
mAb anti-Human IL-6, 2E10MO-C40091B0.1 mg
mAb anti-Human IL-6, 8E10MO-C40091C0.1 mg
mAb anti-Human IL-6, 5G8MO-C40091D0.1 mg
mAb anti-Human IL-6, 1B6MO-C40091E0.1 mg
mAb anti-Human IL-6, 1E3MO-C40091F0.1 mg
mAb anti-Human IL-6, 6D7MO-C40091G0.1 mg
mAb anti-Human IL-6, 9D8MO-C40091H0.1 mg
mAb anti-Human IL-10, 4H2MO-C40092A0.1 mg
mAb anti-Human IL-10, 6D2MO-C40092B0.1 mg
mAb anti Human IL-17A clone 4C1, CaptureMO-C40093A0.1mg
mAb anti Human IL-17A clone 2F3MO-C40093B0.1mg
mAb anti Human IL-17A clone 8H7MO-C40093C0.1mg
mAb anti Human IL-17A clone 5B4MO-C40093D0.1mg
mAb anti Human IL-17A clone 1E2MO-C40093E0.1mg
mAb anti Human IL-17A clone 2D11MO-C40093H0.1mg
mAb anti Human IL-17A clone 3C1MO-C40093I0.1mg
mAb anti Human IL-17A clone 3H11, DetectorMO-C40093K0.1mg
mAb anti Human IL-17A clone 5A9MO-C40093M0.1mg
mAb anti Human IL-17A clone 6F12MO-C40093O0.1mg
mAb anti Human IL-17A clone 7F10MO-C40093S0.1mg
mAb anti Human IL-17A clone 10F9MO-C40093W0.1mg
mAb anti Human IL-18 clone 2A10, CaptureMO-C40094A0.1mg
mAb anti Human IL-18 clone 10H4, DetectorMO-C40094B0.1mg
mAb anti human IL-18 clone 10H4, Tracer (Biotin Labeled)MO-C40094TB0.1 mL
mAb anti Human IL-15 clone 5E8, CaptureMO-C40095A0.1mg
mAb anti Human IL-15 clone B1H6, DetectorMO-C40095B0.1mg
mAb anti-human LIF, Clone 2C6MO-C40096A0.1mg
mAb anti-human LIF, Clone 3F4MO-C40096B0.1mg
mAb anti-human LIF, Clone 8B10MO-C40096C0.1mg
mAb anti-DYKDDDDK (Flag) Tag, Flag.10F4MO-H40001B0.1 mg
mAb anti-GAPDH, H8MO-H40002A0.1 mg
mAb anti-HA Tag, HA52MO-H40004A0.1 mg
mAb anti-His Tag, 10A12MO-H40005B0.1 mg
mAb anti-Myc Tag, MycA7MO-H40006A0.1 mg
mAb anti-V5 Tag, V531MO-H40007A0.1 mg
mAb anti-HIV-1 P24 (Core Protein), 473, DetectorMO-I40002A0.1 mg
mAb anti-HIV-1 P24 (Core Protein), 163MO-I40002C0.1 mg
mAb anti-HIV-1 P24 (Core Protein), 340, CaptureMO-I40002D20.1 mg
mAb anti-HIV-1 P24 (Core Protein), 587, 0.1 mgMO-I40002E0.1 mg
mAb anti-HIV-1 P24 (Core Protein), 425MO-I40002I0.1 mg
mAb anti-HIV-1 P24 (Core Protein), 1027MO-I40002J0.1 mg
mAb anti-HIV-1 P24 (Core Protein), 287MO-I40002N0.1 mg
mAb anti-HIV-1 P24 (Core Protein), 161MO-I40002P0.1 mg
mAb anti-HBsAg, RM-1MO-I40013A0.1 mg
mAb anti-HCV Core Protein, A1/3D1MO-I40015A0.1 mg
mAb anti-HCV Core Protein, B2MO-I40015B0.1 mg
mAb anti-HCV Core Protein, C3MO-I40015E0.1 mg
mAb anti-HCV NS-4, 7B7/5G9MO-I40016B0.1 mg
mAb anti-HCV NS-4, 5D4/10E7MO-I40016D0.1 mg
mAb anti-HCV NS-4, 7E11MO-I40016F0.1 mg
mAb anti-HCV NS-4, 202MO-I40016J0.1 mg
mAb anti-HCV NS-4, 101MO-I40016K0.1 mg
mAb anti-HCV NS-4, 174MO-I40016L0.1 mg
mAb anti-HCV NS-4, 497MO-I40016M0.1 mg
mAb anti-HCV NS-3, 70-13MO-I40018A0.1 mg
mAb anti-HCV NS-3, 1-5MO-I40018B0.1 mg
mAb anti-HCV NS-3, 12-15MO-I40018D0.1 mg
mAb anti-HCV NS-3, 5-11MO-I40018E0.1 mg
mAb anti-HCV NS-3, 24-8MO-I40018F0.1 mg
mAb anti-HCV NS-3, 20-8MO-I40018G0.1 mg
mAb anti-HCV NS-3, 113MO-I40018H0.1 mg
mAb anti-HCV NS-3, 281MO-I40018J0.1 mg
mAb anti-HCV NS-3, 806MO-I40018K0.1 mg
mAb anti-HCV NS-3, 5MO-I40018L0.1 mg
mAb anti-HCV NS-3, 328MO-I40018M0.1 mg
mAb anti-HCV NS-3, 251MO-I40018N0.1 mg
mAb anti-HCV NS-3, 242MO-I40018P0.1 mg
mAb anti-HCV NS-3, 133MO-I40018Q0.1 mg
mAb anti-HEV, S-13MO-I40019B0.1 mg
mAb anti-HEV, 4H5MO-I40019C0.1 mg
mAb anti-HEV, 2H6MO-I40019D0.1 mg
mAb anti-HEV, 2H2MO-I40019E0.1 mg
mAb anti-HEV, 1B6MO-I40019F0.1 mg
mAb anti-HEV, 5H4MO-I40019G0.1 mg
mAb anti-HP CagA, 10E9,MO-I40020A0.1 mg
mAb anti-HP CagA, 5H10MO-I40020B0.1 mg
mAb anti-HP CagA, 5C6MO-I40020C0.1 mg
mAb anti-HP CagA, 3C10,MO-I40020D0.1 mg
mAb anti-HP CagA, 3C1MO-I40020E0.1 mg
mAb anti-TB 38KD Antigen, D2G2MO-I40021A0.1 mg
mAb anti-TB 38KD Antigen, C12H11MO-I40021B0.1 mg
mAb anti-TB 38KD Antigen, C11B10MO-I40021C0.1 mg
mAb anti-TB 38KD Antigen, B12F8MO-I40021D0.1 mg
mAb anti-TB 38KD Antigen, A11D2MO-I40021E0.1 mg
mAb anti-TB 38KD Antigen, A2H8MO-I40021F0.1 mg
mAb anti-Human CD3, JXT3MO-L40001A0.1 mg
Rat anti-Mouse CD4, JXYT4MO-L400260.1 mg
Rat anti-Mouse CD8, JXYT8MO-L400270.1 mg
mAb anti-Human CD11α, A11MO-L400280.1 mg
mAb anti-Human HLA-ABC, LY5.1MO-L400330.1 mg
mAb anti-Human CD71 Transferrin Receptor, CY-TFRMO-L400420.1 mg
mAb anti-Human PD-1 / CD279, 1C4MO-L40043A0.1 mg
mAb anti-Human PD-1 / CD279, 7C9, CaptureMO-L40043B0.1 mg
mAb anti-Human PD-1 / CD279, 9E11MO-L40043E0.1 mg
mAb anti-Human PD-1 / CD279, 9B4MO-L40043F0.1 mg
mAb anti-Human PD-1 / CD279, B1C4MO-L40043G0.1 mg
mAb anti-Human PD-1 / CD279, 7G12, DetectorMO-L40043L0.1 mg
mAb anti-Human PD-1 / CD279, 2H7MO-L40043M0.1 mg
mAb anti Human PD-L1, clone 6A5MO-L40044E0.1 mg
mAb anti Human PD-L1 clone 8C12MO-L40044F0.1 mg
mAb anti Human PD-L1 clone 12B4, DetectorMO-L40044I0.1 mg
mAb anti Human PD-L1 clone 11D11MO-L40044M0.1 mg
mAb anti Human PD-L1 clone 15G3, CaptureMO-L40044N0.1 mg
mAb anti Human PD-L1 clone 12D9MO-L40044O0.1 mg
mAb anti Human PD-L1 clone 15F2MO-L40044R0.1 mg
mAb anti Human PD-L1, clone 10B12MO-L40044S0.1 mg
mAb anti Human CD47, clone 1G10MO-L40045A0.1 mg
mAb anti Human CD47, clone 8H7MO-L40045B0.1 mg
mAb anti Human CD47, clone 9F10MO-L40045C0.1 mg
mAb anti Human CD44, clone 2G7MO-L40046A0.1 mg
mAb anti Human CD44, clone 3C7MO-L40046B0.1 mg
mAb anti-hCG-α, CH5MO-M40010A0.1 mg
mAb anti-hCG-α, CH7MO-M40010B0.1 mg
mAb anti-TRICHOSANTHIN (TCST), TCST-1, 0.1 mgMO-M40011A0.1 mg
mAb anti-hGH, YC6, CaptureMO-M40012A0.1 mg
mAb anti-Human Ig Kappa Light Chain, YCK1MO-M400200.1 mg
mAb anti-Human B2MG, D6E4MO-M40021B0.1 mg
mAb anti-Human B2MG, D2E9, CaptureMO-M40021C0.1 mg
mAb anti-Human B2MG, D6D1MO-M40021D0.1 mg
mAb anti-Human B2MG, D2A10MO-M40021E0.1 mg
mAb anti-Human B2MG, D3A2, DetectorMO-M40021F0.1 mg
mAb anti-human CRP, 63F4, CaptureMO-M40023A0.1 mg
mAb anti-human CRP, 67A1MO-M40023B0.1 mg
mAb anti-human CRP, N1G1MO-M40023D0.1 mg
mAb anti-human CRP, S5G1MO-M40023E0.1 mg
mAb Rat anti-Aflatoxin, 1C6, 0.1 mgMO-M40025A0.1 mg
mAb Rat anti-Aflatoxin, 1E6, 0.1 mgMO-M40025B0.1 mg
mAb Rat anti-Aflatoxin, 2E4MO-M40025D0.1 mg
mAb anti-Human Albumin, S4D6MO-M400360.1 mg
mAb anti-Human Factor IX, F9-1, .01 mgMO-M400370.1 mg
mAb anti-Human Protein C, HLW-C, 0.1 mgMO-M400380.1 mg
mAb anti-Human Factor X, F10-1, 0.1 mgMO-M400390.1 mg
mAb anti-Human GP IIb/IIIa, 237, 0.1 mgMO-M40040A0.1 mg
mAb anti-Human GP IIb/IIIa, 474, 0.1 mgMO-M40040B0.1 mg
mAb anti-Human GP IIb/IIIa, Y8MO-M40040D0.1 mg
mAb anti-Human GP IIb/IIIa, 700MO-M40040E0.1 mg
mAb anti-Human GP IIb/IIIa, 585MO-M40040F0.1 mg
mAb anti-Human GP IIb/IIIa, 8MO-M40040H0.1 mg
mAb anti-Human GP IIb/IIIa, 291MO-M40040J0.1 mg
mAb anti-Human GP IIb/IIIa, 262MO-M40040N0.1 mg
mAb anti-Human GP IIb/IIIa, 71MO-M40040Q0.1 mg
mAb anti-Human GP IIb/IIIa, 128MO-M40040S0.1 mg
mAb anti-Staphylococcal Enterotoxin B [SEB], 0.1 mgMO-M400410.1 mg
mAb anti-Human PTP1-C, PTY6MO-M40043A0.1 mg
mAb anti-Human PTP1-C, PTY11MO-M40043B0.1 mg
mAb anti-Human PTP1-C, PTY15MO-M40043D0.1 mg
mAb anti-Human PTP1-C, PTY10MO-M40043E0.1 mg
mAb anti-Human PTP1-C, PTY13MO-M40043F0.1 mg
mAb anti-human TSH, TSH-2, DetectorMO-M40046A0.1 mg
mAb anti-human TSH, TSH-1, CaptureMO-M40046B0.1 mg
mAb anti-Human Prolactin, PRL-1, CaptureMO-M40047B0.5 mg
mAb anti-Human LH, LH-1, CaptureMO-M40048B0.5 mg
mAb anti-hCG, HCG-1, CaptureMO-M40049B0.5 mg
mAb anti-Human FSH, FSH-1, CaptureMO-M40050B0.5 mg
mAb anti-Human Raf-1, 410MO-M40091E0.5 mg
mAb anti-Human Raf-1, 540MO-M40091G0.5 mg
mAb anti-Human Raf-1, 863MO-M40091J0.5 mg
mAb anti-Human Raf-1, 163MO-M40091M0.5 mg
mAb anti-Human NSE, 145MO-M40092A0.5 mg
mAb anti-Human NSE, 1G6MO-M40092B0.5 mg
mAb anti-Human NSE, 171MO-M40092C0.5 mg
mAb anti-Amyloid β Peptide 42, CA9 3B3MO-M40093A0.1 mg
mAb anti-Amyloid β Peptide 42, CA9 10C11, DetectorMO-M40093B0.5 mg
mAb anti-Amyloid β Peptide 42, CA9 3F8MO-M40093D0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 3F5MO-M40094A0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 1H3MO-M40094B0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 6C8MO-M40094C0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 5B8, CaptureMO-M40094D0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 4A2MO-M40094E0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 7H7MO-M40094F0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 5A4MO-M40094G0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 4B7MO-M40094H0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 7G10MO-M40094I0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 1F10MO-M40094J0.5 mg
mAb anti-Amyloid β Peptide 40, CV9 7B10, DetectorMO-M40095A0.1 mg
mAb anti-Amyloid β Peptide 40, CV9 8B2MO-M40095B0.1 mg
mAb anti-Amyloid β Peptide 40, 4B1MO-M40095C0.1 mg
mAb anti-Human α1-antitrypsin, 5G5MO-M40096A0.1 mg
mAb anti-Human α1-antitrypsin, 9F2MO-M40096B0.1 mg
mAb anti-Human α-Synuclein, 4H11MO-M40097A0.1 mg
mAb anti-Human α-Synuclein, 4C1MO-M40097B0.1 mg
mAb anti-Human α-Synuclein, 4B4MO-M40097C0.1 mg
mAb anti-Human α-Synuclein, 8F12MO-M40097D0.1 mg
mAb anti-Human α-Synuclein, 9A9MO-M40097E0.1 mg
mAb anti-Human α1-antichymotrypsin, 3E11MO-M40098A0.1 mg
mAb anti-Human α1-antichymotrypsin, B2B3MO-M40098B0.1 mg
mAb anti-Human α1-antichymotrypsin, B4H12MO-M40098C0.1 mg
mAb anti-Human α1-antichymotrypsin, B5B11MO-M40098D0.1 mg
mAb anti-Human α1-antichymotrypsin, B7B10MO-M40098E0.1 mg
mAb anti-Human α1-antichymotrypsin, B7H2MO-M40098F0.1 mg
mAb anti-Thr181 Phosphorylated Tau, 1A4MO-M40099A0.1 mg
mAb anti-Thr181 Phosphorylated Tau, 7G9MO-M40099B0.1 mg
mAb anti-Thr181 Phosphorylated Tau, 9B4MO-M40099C0.1 mg
mAb anti-Thr181 Phosphorylated Tau, 2A4MO-M40099D0.1 mg
mAb anti-human Thr212 Thr217 double phosphorylated Tau, 8E1MO-M40100A0.1 mg
mAb anti-human Thr212 Thr217 double phosphorylated Tau, 1G8MO-M40100B0.1 mg
mAb anti-human Thr212 Thr217 double phosphorylated Tau, 4C1MO-M40100C0.1 mg
mAb anti-human Thr212 Thr217 double phosphorylated Tau, 3B12MO-M40100D0.1 mg
mAb anti-human Thr212 Thr217 double phosphorylated Tau, 4H1MO-M40100E0.1 mg
mAb anti-human Thr212 Thr217 double phosphorylated Tau, 4H11MO-M40100F0.1 mg
mAb anti-human Thr212 Thr217 double phosphorylated Tau, 5C11MO-M40100G0.1 mg
mAb anti-human Thr212 Thr217 double phosphorylated Tau, 10G9MO-M40100H0.1 mg
mAb anti-LCRMP4, 5H5MO-M40101A/
mAb anti-LCRMP4, 2H7MO-M40101B/
mAb anti-LCRMP4 , 7E1MO-M40101C/
mAb anti-Human Phospho-STAT5b [p-Y699], A4B9MO-P40001A0.1 mg
mAb anti-Human Phospho-STAT5b [p-Y699], A2H6MO-P40001B0.1 mg
mAb anti-Human Phospho-ELK-1 [p-S383], B4A12MO-P40002A0.1 mg
mAb anti-Human Phospho-ELK-1 [p-S383], D7H2MO-P40002B0.1 mg
mAb anti-Human Phospho-CREB [p-S133], A3A4MO-P40003A0.1 mg
mAb anti-Human Phospho-CREB [p-S133], B1C4MO-P40003B0.1 mg
mAb anti-Human FPRL-1 C-terminal, C4F9MO-P40006A0.1 mg
mAb anti-Human FPRL-1 C-terminal, B4D9B10MO-P40006B0.1 mg
mAb anti-Human FPRL-1 2nd extracellular loop, 3D7MO-P40007A0.1 mg
mAb anti-Human FPRL-1 2nd extracellular loop, B7H10MO-P40007B0.1 mg
mAb anti-Human Lung Carcinoma, CHALU2MO-T40005B0.1 mg
mAb anti-Human Lung Carcinoma, 3504MO-T40005C0.1 mg
mAb anti-Human Hepatocellular Carcinoma, CHALV1MO-T40006A0.1 mg
mAb anti-Human AFP, AFP-Y2, DetectorMO-T40007A0.1 mg
mAb anti-Human AFP, AFP-Y1, CaptureMO-T40007B0.1 mg
mAb anti-Human BPH, YBPH-1MO-T40008A0.1 mg
mAb anti-Human BPH, YBPH-2MO-T40008B0.1 mg
mAb anti-Human PML, B3E9MO-T40010A0.1 mg
mAb anti-Human PML, B4C8MO-T40010B0.1 mg
mAb anti-CA 125, 110MO-T40012A0.1 mg
mAb anti-CA 125, 76MO-T40012B0.1 mg
mAb anti-CA 125, 23MO-T40012C0.1 mg
mAb anti-CA 125, 15MO-T40012D0.1 mg
mAb anti-CA 125MO-T40012E0.1 mg
mAb anti-CA50, 93MO-T40014A0.1 mg
mAb anti-CA50, 826MO-T40014B0.1 mg
mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,8E2 (Free Sample Available)MO-T40015A0.1 mg
mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,9B2 (Free Sample Available)MO-T40015B0.1 mg
mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,1A5 (Free Sample Available)MO-T40015C0.1 mg
mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,4E11 (Free Sample Available)MO-T40015D0.1 mg
mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,9E1 (Free Sample Available)MO-T40015E0.1 mg
mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,7C4 (Free Sample Available)MO-T40015F0.1 mg
mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,7E6 (Free Sample Available)MO-T40015G0.1 mg
mAb anti-Human Colorectal Carcinoma, Y94MO-T400220.1 mg
mAb anti-Human Colorectal Carcinoma/CD3, BS-1MO-T400350.1 mg
mAb anti-Human CEA, CEA-Y2, DetectorMO-T40051A0.1 mg
mAb anti-Human CEA, CEA-Y1, CaptureMO-T40051B0.1 mg
mAb anti-Human Free PSA, 103, DetectorMO-T40052A0.1 mg
mAb anti-Human Free PSA, 108, CaptureMO-T40052B0.1 mg
mAb anti-Human PSA, CHYH1, CaptureMO-T40081A0.1 mg
mAb anti-Human PSA, CHYH2, DectectorMO-T40081B0.1 mg
mAb anti-Human PMA, YPMA-1MO-T40083A0.1 mg
mAb anti-Human PMA, YPMA-2MO-T40083B0.1 mg
mAb anti-Human PSP, YPSP-1MO-T40085A0.1 mg
mAb anti-Human PSP, YPSP-2MO-T40085B0.1 mg
mAb anti-Human PSP, YPSP-3MO-T40085C0.1 mg
mAb anti-Human PSP, YPSP-4MO-T40085D0.1 mg
mAb anti-Human PSMA, YPSMA-1MO-T40086A0.1 mg
mAb anti-Human PSMA, YPSMA-2MO-T40086B0.1 mg
mAb anti-Human PSMA, 4H11MO-T40086C0.1 mg
mAb anti-Human PSMA, 7F3MO-T40086D0.1 mg
mAb anti-Human PTMA, 8H12MO-T40087A0.1 mg
mAb anti-Human PTMA, 9A10MO-T40087B0.1 mg
mAb anti-Human PTMA, 6A3MO-T40087C0.1 mg
mAb anti-Human PTMA, 4G2MO-T40087D0.1 mg
mAb anti-Human PTMA, 5A10MO-T40087E0.1 mg
mAb anti-Human PTMA, 6H7MO-T40087F0.1 mg
mAb anti-Human PTMA, 1F2, CaptureMO-T40087G0.1 mg
mAb anti-Human PTMA, 4C3MO-T40087H0.1 mg
mAb anti-Human PTMA, 4A7, DetectorMO-T40087I0.1 mg
mAb anti-Human S100A7 (psoriasin), 9A4MO-T40088A0.1 mg
mAb anti-Human S100A7 (psoriasin), 2E6MO-T40088B0.1 mg
mAb anti-Human S100A7 (psoriasin), 1A10MO-T40088C0.1 mg
mAb anti-Human S100A7 (psoriasin), 5C2MO-T40088D0.1 mg
mAb anti-Human S100A7 (psoriasin), 10H9MO-T40088E0.1 mg
mAb anti-Human S100A7 (psoriasin), 2A3MO-T40088F0.1 mg
mAb anti-Human S100A7 (psoriasin), 2E5MO-T40088G0.1 mg
mAb anti-Human S100A7 (psoriasin), 5H12MO-T40088H0.1 mg
mAb anti-Human S100A7 (psoriasin), 9C7MO-T40088I0.1 mg
mAb anti-Human S100A7 (psoriasin), 9D5MO-T40088J0.1 mg
mAb anti-Human S100A7 (psoriasin), 3E7MO-T40088K0.1 mg
Human PSA ELISA KitEL1000596 wells
Human IL-8 ELISA KitEL1000896 wells
Human MCAF / MCP-1 ELISA KitEL1000996 wells
Human EGF ELISA KitEL1001096 wells
Human LH ELISA KitEL1001196 wells
Human TSH ELISA KitEL1001296 wells
Neonatal TSH ELISA KitEL10012N96 wells
Ultra-Sensitive Human TSH ELISA KitEL10012U96 wells
Human FSH ELISA KitEL1001396 wells
Human Prolactin ELISA KitEL1001496 wells
Human SAA ELISA KitEL1001596 wells
Human SAA ELISA Kit (2nd Generation)EL10015L96 wells
Human MCP-3 ELISA KitEL1001696 wells
Human TNF-α ELISA KitEL1001996 wells
Human GM-CSF ELISA KitEL1002096 wells
Human IL-16 ELISA KitEL1002196 wells
High Sensitivity Human CRP ELISA KitEL10022hs96 wells
Human IL-6 ELISA KitEL1002396 wells
Human IFN-γ ELISA KitEL1002496 wells
Human IL-2 ELISA KitEL1002596 wells
Human IL-4 ELISA KitEL1002696 wells
Human IL-10 ELISA KitEL1002796 wells
Human IL-1β ELISA KitEL1002896 wells
Human TGF-β1 ELISA KitEL1002996 wells
Human Growth Hormone (hGH) ELISA Kit/Hormone ElisaEL1003096 wells
High Sensitivity Human Growth Hormone (H-hGH) ELISA KitEL10030H96 wells
Human Chorionic Gonadotropin (hCG) ELISA KitEL1003196 wells
Human IL-12 (P70) ELISA KitEL1003296 wells
Human IL-2 sRα ELISA KitEL1003396 wells
Human IL-6 sR ELISA KitEL1003496 wells
Human IL-5 ELISA KitEL1003596 wells
HAMA ELISA KitEL1003696 wells
Human IL-13 Rα2 ELISA KitEL1003996 wells
Human IL-1α ELISA KitEL1004096 wells
Human IL-7 ELISA KitEL1004196 wells
Human IL-11 ELISA KitEL1004296 wells
Human IL-15 ELISA KitEL1004496 wells
Human M-CSF ELISA KitEL1004696 wells
Human TNF-β ELISA KitEL1004796 wells
Human bFGF ELISA KitEL1004896 wells
Human Alphafetoprotein (AFP) ELISA KitEL1004996 wells
Human B2MG ELISA KitEL1005196 wells
Human Carcinoembryonic Antigen (CEA) ELISA KitEL1005296 wells
Human IL-17A ELISA KitEL1005396 wells
Human IL-13 ELISA KitEL1005496 wells
Human IL-22 ELISA KitEL1005596 wells
Human IL-9 ELISA KitEL1005696 wells
Human Amyloid Beta Peptide 42 ELISA KitEL1005796 wells
Human Programmed Death-Ligand 1 (PD-L1) ELISA KitEL1005896 wells
Human Programmed Death-1 (PD-1) ELISA KitEL1005996 wells
Human IL-18 ELISA KitEL1006096 wells
Multiplex Human Cytokine ELISA Kit (Inflammatory)EM1000196 wells
Multiplex Human Cytokine ELISA Kit (M1/M2/MDSC Cytokines)EM1000296 wells
Multiplex Human Cytokine ELISA Kit (Th1/Th2/Th17)EM1000396 wells
Mouse IL-17A ELISA KitMEC100196 wells
Mouse IFN-γ ELISA KitMEC100296 wells
Mouse TNF-α ELISA KitMEC100396 wells
Mouse GM-CSF ELISA KitMEC100496 wells
Mouse MCP-1 ELISA KitMEC100596 wells
Mouse IL-2 ELISA KitMEC100696 wells
Mouse IL-5 ELISA KitMEC100796 wells
Mouse IL-6 ELISA KitMEC100896 wells
Mouse IL-4 ELISA KitMEC100996 wells
Mouse IL-1β ELISA KitMEC101096 wells
Mouse IL-1α ELISA KitMEC101196 wells
Mouse TGF-β1 ELISA KitMEC101296 wells
pAb anti-Human CRP, Tracer (HRP Labeled)AI20009P0.2 mL
mAb anti-Human TNF-α, CH8820, CaptureMO-C40003B0.1 mg
mAb anti-Human TNF-α, B1E4, DetectorMO-C40003E0.1 mg
mAb anti-Human TNF-α, B1E4, Tracer (HRP Labeled)MO-C40003T0.2 mL
mAb anti-Human TNF-α, B1E4, Tracer (Biotin Labeled)MO-C40003TB0.1 mL
mAb anti-Human IL-8, I8-S2, CaptureMO-C40017A0.1 mg
mAb anti-Human IL-8, I8-60, DetectorMO-C40017D0.1 mg
mAb anti-Human IL-8, I8-60, Tracer (HRP Labeled)MO-C40017T0.2 mL
mAb anti-Human IL-8, I8-60, Tracer (Biotin Labeled)MO-C40017TB0.1 mL
mAb anti-Human MCP-1, S14, CaptureMO-C40021B0.1 mg
mAb anti-Human MCP-1, S101, DetectorMO-C40021D0.1 mg
mAb anti-Human MCP-1, S101, Tracer (HRP Labeled)MO-C40021T0.2 mL
mAb anti-Human MCP-1, S101, Tracer (Biotin Labeled)MO-C40021TB0.1 mL
mAb anti-Human SAA, 115, CaptureMO-C40028A0.1 mg
mAb anti-Human SAA, 607, DetectorMO-C40028E0.1 mg
mAb anti-Human SAA, 607, Tracer (HRP Labeled), 0.2mLMO-C40028T0.2 mL
mAb anti-Human SAA, 607, Tracer (Biotin Labeled), 0.1mLMO-C40028TB0.1 mL
mAb anti-Human EGF, S-134, CaptureMO-C40044D0.1 mg
mAb anti-Human EGF, S-146, DetectorMO-C40044F0.1 mg
mAb anti-Human EGF, S-146, Tracer (HRP Labeled)MO-C40044T0.2 mL
mAb anti-Human EGF, S-146, Tracer (Biotin Labeled)MO-C40044TB0.1 mL
mAb anti-Human MCP-3, 113, DetectorMO-C40088A0.1 mg
mAb anti-Human MCP-3, 542, CaptureMO-C40088G0.1 mg
mAb anti-Human MCP-3, 113, Tracer (HRP Labeled)MO-C40088T0.2 mL
mAb anti-Human MCP-3, 113, Tracer (Biotin Labeled)MO-C40088TB0.1 mL
mAb anti-Human IL-16, 323, DetectorMO-C40089J0.1 mg
mAb anti-Human IL-16, 398, CaptureMO-C40089K0.1 mg
mAb anti-Human IL-16, 323, Tracer (HRP Labeled)MO-C40089T0.2 mL
mAb anti-Human GM-CSF, 59, CaptureMO-C40090B0.1 mg
mAb anti-Human GM-CSF, 429, DetectorMO-C40090D0.1 mg
mAb anti-Human GM-CSF, 429, Tracer (HRP Labeled)MO-C40090T0.2 mL
mAb anti-Human GM-CSF, 429, Tracer (Biotin Labeled)MO-C40090TB0.1 mL
mAb anti Human IL-18 clone 2A10, CaptureMO-C40094A0.1mg
mAb anti Human IL-18 clone 10H4, DetectorMO-C40094B0.1mg
mAb anti human IL-18 clone 10H4, Tracer (Biotin Labeled)MO-C40094TB0.1 mL
mAb anti Human IL-15 clone 5E8, CaptureMO-C40095A0.1mg
mAb anti Human IL-15 clone B1H6, DetectorMO-C40095B0.1mg
mAb anti human IL-15 clone B1H6, Tracer (Biotin labeled)MO-C40095TB0.1 mL
mAb anti-HIV-1 P24 (Core Protein), 473, DetectorMO-I40002A0.1 mg
mAb anti-HIV-1 P24 (Core Protein), 340, CaptureMO-I40002D20.1 mg
mAb anti-HIV-1 P24 (Core Protein), 473, Tracer (HRP), 0.2 mLMO-I40002T20.2 mL
mAb anti-Human PD-1 / CD279, 7G12, Tracer (Biotin labeled)MO-L40043TB0.1 mL
mAb anti Human PD-L1 clone 12B4, DetectorMO-L40044I0.1 mg
mAb anti Human PD-L1 clone 15G3, CaptureMO-L40044N0.1 mg
mAb anti human PD-L1 clone 12B4, Tracer (Biotin Labeled)MO-L40044TB0.1 mL
mAb anti-hGH, YC6, CaptureMO-M40012A0.1 mg
mAb anti-hGH, YC8, Tracer (HRP Labeled), 0.2 mLMO-M40012T0.2 mL
mAb anti-hGH, YC8, Tracer (Biotin Labeled), 0.1 mLMO-M40012TB0.1 mL
mAb anti-Human B2MG, D2E9, CaptureMO-M40021C0.1 mg
mAb anti-Human B2MG, D3A2, DetectorMO-M40021F0.1 mg
mAb anti-Human B2MG, D3A2, Tracer (HRP Labeled), 0.2mLMO-M40021T0.2 mL
mAb anti-human CRP, 63F4, CaptureMO-M40023A0.1 mg
mAb anti-human TSH, TSH-2, DetectorMO-M40046A0.1 mg
mAb anti-human TSH, TSH-1, CaptureMO-M40046B0.1 mg
mAb anti-human TSH, TSH-2, Tracer (HRP Labeled), 0.2 mLMO-M40046T0.2 mL
mAb anti-Human Prolactin, PRL-1, CaptureMO-M40047B0.5 mg
mAb anti-Human Prolactin, PRL-2, Tracer (HRP Labeled), 0.2 mLMO-M40047T0.2 mL
mAb anti-Human LH, LH-1, CaptureMO-M40048B0.5 mg
mAb anti-Human LH, LH-2, Tracer (HRP Labeled), 0.2 mLMO-M40048T0.2 mL
mAb anti-hCG, HCG-1, CaptureMO-M40049B0.5 mg
mAb anti-hCG, HCG-2, Tracer (HRP Labeled), 0.2 mLMO-M40049T0.2 mL
mAb anti-Human FSH, FSH-1, CaptureMO-M40050B0.5 mg
mAb anti-Human FSH, FSH-2, Tracer (HRP Labeled)MO-M40050T0.2 mL
mAb anti-Amyloid β Peptide 42, CA9 10C11, DetectorMO-M40093B0.5 mg
mAb anti-Amyloid β Peptide 42, CA9 10C11, Tracer (Biotin)MO-M40093TB0.1 mL
mAb anti-Amyloid β Peptide N-terminal, NT 5B8, CaptureMO-M40094D0.5 mg
mAb anti-Amyloid β Peptide 40, CV9 7B10, DetectorMO-M40095A0.1 mg
mAb anti-Amyloid β Peptide 40, CV9 7B10, Tracer (Biotin)MO-M40095TB0.1 mL
mAb anti-Human AFP, AFP-Y2, DetectorMO-T40007A0.1 mg
mAb anti-Human AFP, AFP-Y1, CaptureMO-T40007B0.1 mg
mAb anti-Human AFP, AFP-2, Tracer (HRP Labeled), 0.2 mLMO-T40007T0.2 mL
mAb anti-Human CEA, CEA-Y2, DetectorMO-T40051A0.1 mg
mAb anti-Human CEA, CEA-Y1, CaptureMO-T40051B0.1 mg
mAb anti-Human CEA, CEA-Y2, Tracer (HRP Labeled), 0.2 mLMO-T40051T0.2 mL
mAb anti-Human Free PSA, 103, DetectorMO-T40052A0.1 mg
mAb anti-Human Free PSA, 108, CaptureMO-T40052B0.1 mg
mAb anti-Human Free PSA, 103, Tracer (HRP Labeled), 0.2 mLMO-T40052T0.2 mL
mAb anti-Human PSA, CHYH1, CaptureMO-T40081A0.1 mg
mAb anti-Human PSA, CHYH2, DectectorMO-T40081B0.1 mg
mAb anti-Human PSA, CHYH2, Tracer (HRP Labeled), 0.2 mLMO-T40081T0.2 mL
Human Chorionic Gonadotrophin (hCG), 10 mgAP3000210 mg
Human Immunoglobulin G (IgG), 10 mgIG3000110 mg
Mouse Immunoglobulin G (IgG), 10 mgIG4100210 mg
Mouse Immunoglobulin G2b (IgG2b), 10 mgIG4100410 mg
Rat Immunoglobulin G (IgG)IG4200310 mg
Human Umbilical Cord Serum, 10 mLS3001010 mL
ELISA Coating (EC) Stabilizer, 500 mLS7001500 mL
Human IL-8 Matched Antibody Pair for ELISpotSL10008A5 × 96 wells
Human IL-8 Development Set for ELISpotSL10008B5 × 96 wells
Human IL-8 ELISpot KitSL10008E6 X 96 wells
Human MCAF (MCP-1) Matched Antibody Pair for ELISpotSL10009A5 × 96 wells
Human MCAF (MCP-1) Development Set for ELISpotSL10009B5 × 96 wells
Human MCAF (MCP-1) ELISpot KitSL10009E6 X 96 wells
Human GM-CSF Matched Antibody Pair for ELISpotSL10020A5 × 96 wells
Human GM-CSF Development Set for ELISpotSL10020B5 × 96 wells
Human GM-CSF ELISpot KitSL10020E6 X 96 wells
Human IFN-γ Matched Antibody Pair for ELISpotSL10024A5 × 96 wells
Human IFN-γ Development Set for ELISpotSL10024B5 × 96 wells
Human IFN-γ ELISpot KitSL10024E6 X 96 wells
Human IL-12 (P70) ELISpot KitSL10032E6 X 96 wells
TMB Solution (500 mL Part A & 500 mL Part B)SU60061.0 L
pAb Rabbit anti-HCV Virus, 1.0 mgAI20006P1.0 mg
pAb Rabbit anti-HIV-1 p24, 1.0 mgAI20008P1.0 mg
pAb anti-Human CRP, Tracer (HRP Labeled)AI20009P0.2 mL
pAb Rabbit anti-Mouse IgG , 1.0 mgAI500051.0 mg
pAb Rabbit anti-Mouse IgG - HRP Conjugated, 1.0 mLAI50005P1.0 mL
pAb Rabbit anti-hGH,AI50006P1.0 mg
pAb Chicken anti-human IL-8 (IgY fraction)AI600011.0 mg
pAb Rabbit anti-Human FPRL-1 2nd Extracellular LoopAI70001A0.1 mg
pAb Rabbit anti-Human FPRL-1 C-terminalAI70001B0.1 mg
pAb Rabbit anti-Human PML [Ring Finger Domain]AI70002A0.1 mg
pAb Rabbit anti-Human PML [B-box 1 domain]AI70002B0.1 mg
pAb Rabbit anti-Bcl-2AI70003A0.1 mg
pAb Rabbit anti-Phospho-Bcl-2 (Thr56)AI70003B0.1 mg
pAb Rabbit anti-Phospho-Bcl-xL (Thr115)AI70003D0.1 mg
pAb Rabbit anti-Phospho c-kit (Tyr719)AI70004A0.1 mg
pAb Rabbit anti-Phospho IKK-γ (Ser31)AI70005A0.1 mg
pAb Rabbit anti-NF-κB-p65 (RelA)AI70006A0.1 mg
pAb Rabbit anti-Phospho-NF-қB-p65 (Ser276)AI70007A0.1 mg
pAb Rabbit anti-Phospho-NF-қB-p65 (Ser468)AI70008A0.1 mg
pAb Rabbit anti-Phospho NF-қB-p105/p50 (Ser337)AI70009A0.1 mg
pAb Rabbit anti-Human Serum Albumin (HSA)AI800010.1 mg
pAb Rabbit anti-Human Fibrinogen, 0.1 mgAI800020.1 mg
pAb Rabbit anti-Human TransferrinAI800030.1 mg
pAb Rabbit anti-Human IgA, 0.5 mgAI800040.5 mg
pAb Rabbit anti-human IgM, 0.5 mgAI800050.5 mg
pAb Rabbit anti-Human TREK-1 (K2p2.1)AI80006A0.1 mg
pAb Rabbit anti-Mouse Kchip1AI800070.1 mg
pAb Rabbit anti-Mouse Kchip4AI800080.1 mg
pAb Rabbit anti-Mouse Kv4.3AI80010A0.1 mg
pAb Rabbit anti-Mouse TRPV1AI80011A0.1 mg
pAb Rabbit anti-Mouse TRPV3AI80012A0.1 mg
pAb Rabbit anti-Human JAK2AI80013A0.1 mg
pAb Rabbit anti-Human Glutathione S Transferase (GST), 0.1 mgAI800140.1 mg
pAb Rabbit anti-Human Amyloid beta peptide 42AI900010.1 mg
pAb Rabbit anti-Human Amyloid beta peptide 43AI900020.1 mg


" data-original="http://atto.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Anogen">
Anogen
...
阅读详情

Copyright © 2026 Powered by ATTO-TEC中国区代理商/公司/官网   鄂ICP备10204150号-10 sitemap